Prognostic role of cyclin D1 in non small cell lung cancer: An immunohistochemical analysis

European Journal of Histochemistry

Volumn 41, Issue 2, 1997, Pages 133-138

  Caputi, M ^a   De Luca, L ^a   Papaccio, G ^a   D'Aponte, A ^a   Cavallotti, I ^a   Scala, P ^a   Scarano, F ^a   Manna, M ^a   Gualdiero, L ^a   De Luca, B ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cyclin D1; Immunohistochemistry; Non small cell lung cancer

Indexed keywords

CYCLIN D1; CYCLINE; ONCOPROTEIN; TUMOR MARKER;

ARTICLE; CANCER STAGING; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN D1; CYCLINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030809321     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Baldi A., Esposito V., De Luca A., Howard C.M., Mazzarella G., Baldi F., Caputi M., and Giordano A.: Differential expression of the retinoblastoma gene family members, Rb/ p105, p107, Rb2/p130, in lung cancer. Clinical Cancer Research 2, 1239-1245, 1996.
2. Baldin V., LuKas J., Marcote M.J., Pagano M., and Draetta G.: Cyclin D1 is a nuclear protein required for cell cycle progression in GI. Genes. Dev. 7, 812-21, 1993.
3. Beahrs O.H., Henson D.E., Hutter R.V.P., and Kennedy B.J.: Lung. In: Manual for staging of cancer. 4th ed. Chicago. American Joint Committee on Cancer 115-122, 1992.
4. Betticher D.C., Heighway J., Hasleton P.S., Altermatt H.J., Ryder W.D.J., Cerny T., and Thatcher N.: Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. British J. Cancer 73, 294-300 1996.
5. Ginsberg R.J., Kris M.G., and Armstrong J.G.: Cancer of the lung, non small cell lung cancer. In Cancer: Principles and practice of Oncologv, fourth edn. V.T. de Vita Jr., S. Hellman and S.A. Rosenberg (eds) pp 673-723. JB Lippincott, 1993, Philadelphia.
6. Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A., and Weinberg R.A.: Function of a human cyclin gene as an oncogene. Proc. Acad. Sci. USA 91, 709-13 1994.
7. Jiang W., Zhang Y.J., Kahn S.M., Hollstein M.C., Santefla R.M., Lu S.H., Harris C.C., Montesano R., and Weinstein I.B.: Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA 90, 9026-30 1993.
8. Jares P., Fernandez P.L., Campo E., Nadal A., Bosch F., Aiza G., Nayach I., Traserra J., and Cardesa A.: PRAD-1 cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 54, 4813-17 1994.
9. Lammie G.A., Fantil V., Smith R., Shuuring E., Brookes S., Michalides R., Dickson C., Arnold A., and Peters G.: D11S287, a putative oncogene on chromosome11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to bcl-1. Oncogene 6, 439-44, 1991.
10. Lovec H., Sewing A., Lucibello F.C., Muller R., and Moroy T.: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9, 323-26, 1994.
11. MacLachlan T.K., Sang N., and Giordano A.: Cyclins, cyclin-dependent Kinases and Cdk Inhibitors: Implication in cell cycle control and cancer. Crit. Rev. Eukaryotic Gene Expression 5, 127-56, 1995.
12. Matturri L., and Lavezzi A.M.: Recurrent chromosome alterations in non small lung cancer. Eur. J. Histochem. 38, 53-58, 1994.
13. Motokura T., and Arnold A.: Cyclins and oncogenesis. Biochim Biophys Acta 1155, 63-78, 1993.
14. Muller D., Millon R., Lidereau R., Engelmann A., Bronner G., Flesh H., Eber M., Methlin G., and Abecassis J.: Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur. J. Cancer b. Oral. Oncol. 30, 113-120, 1994.
15. Muretto P.: Lymphoid follicles in extranodal sites: an himmunohistochemical study. Eur. J. Histochem. 38, 219-28, 1994.
16. Musgrove E. A., Lee C. S.L., Buckley M.F. and Sutherland R L.: Cyclin D1 induction in breast cancer cells shorten G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA 91, 8022-26, 1994.
17. Quelle D.E., Ashmun R.A., Shurdeff S.A., Kato J.Y., Bar-Sagi D., Roussel M.F., and Sherr C.J.: Overexpression of mouse D-type cyclins accelerate GI phase in rodent fibroblast. Genes. Dev. 7, 1559-71, 1993.
18. Shapiro G.I., Ewards C.D., Kobzik L., Godleski J., Richards W., Sugarbaker D.J., and Rollins B.J.: Reciprocal Rb Inactivation and p161NK4 expression in primary lung cancers and cell lines. Cancer Res. 55, 505-09, 1995.
19. Shottenfeld D.: Epidemiology of lung cancer. In Lung Cancer: Principles and Practice, ed. by Pass H.I., Mitchell J.B., Johnson, Turrisi A.T. Lippincot-Raven Publishers. Philadelphia, 1996.
20. William M.E., Gaffev M.J., Weiss L.M., Wilczynski S.P., Schuurind E., and Levine P.A.: Chromosome 11q13 amplification in head and neck squamous carcinoma. Arch. Otoryngol. Head Neck Surg. 119, 1238-43, 1993.
21. World Health Organization: Histological typing of lung tumors. 2nd ed., Geneva 25-26, 1981. Oncogene 8, 1913-19, 1993.
22. World Health Organization: Histological typing of lung tumors. 2nd ed., Geneva 25-26, 1981. Oncogene 8, 1913-19, 1993.
23. Xiong Y., Connolly T., Futcher B., and Beach D.: Human D-type cyclin. Cell 65, 691-99, 1991.